World CDx Boston 2018

Date: 2018/10/02 - 2018/10/05

Location: Boston, MA

Additional info: The Renaissance Boston Waterfront

Address: 606 Congress St Boston, MA 02210, USA

Country: United States

Clinical Biomarkers and World CDx Boston 2018 logo final

Clinical Biomarker Implementation & Validation Track

Accelerating the Demonstration of Clinical Utility and Regulatory Success for Diagnostic-Enabled Therapies


Dan Edelstein, Ph.D.,
Director, Director, Clinical Diagnostics New Technology, Sysmex Inostics Inc.

"OncoBEAM and Plasma Safe Sequencing: Highly Sensitive Liquid Biopsy Technologies for Clinical Trials and Clinical Practice"

• The OncoBEAM™ Platform has been validated across cancer types with sensitivity of around 0.02% MF - new SafeSeq NGS assays is the next generation of highly sensitive technologies for oncology
• Sensitivity matters in liquid biopsies for accurate biomarker detection and patient classification
• Sysmex Inostics OncoBEAM™ and SafeSeq NGS assays are available for CRO services and/or Patient testing globally

Tags: Events

Back to list